A Personalized Mind-Body Intervention (MBI) for Improving Sleep Among Women Working in Healthcare
A Personalized (N-of-1) Trial for Testing the Effect of a Mind-Body Intervention (MBI) on Sleep Duration and Quality in Middle-Aged Women Working in Healthcare
2 other identifiers
interventional
60
1 country
1
Brief Summary
The goal of this pilot study is to determine if a personalized trial testing a Mind-Body Intervention (MBI) can produce a meaningful increase in the average daily sleep duration among women 40-60 years of age working in healthcare. A total of 60 eligible participants will be randomized to one of two possible orders of treatment exposure comprised of three components: mindfulness, yoga, and guided walking, each assigned in 2-week block sequences for a total period of 12 weeks. The study will include a 2-week baseline period during which their baseline sleep duration and adherence to the Fitbit wear and survey submission will be assessed. Following the 2-week run-in period, participants deemed eligible and achieved at least 80% adherence of Fitbit wear and survey submission will be randomized to one of the two intervention arms. Exploratory aims include assessments of sleep quality, physiological factors and their direct and indirect relationships with participants' perceived stress, anxiety, and depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 13, 2023
CompletedFirst Posted
Study publicly available on registry
March 29, 2023
CompletedStudy Start
First participant enrolled
May 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 3, 2025
CompletedResults Posted
Study results publicly available
February 2, 2026
CompletedFebruary 2, 2026
January 1, 2026
1.6 years
March 13, 2023
December 17, 2025
January 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean Within-Subject Difference in Daily Sleep Duration
The effect of the personalized MBI intervention on individual's sleep duration will be assessed in each arm separately. Participants' daily sleep duration will be measured objectively using Fitbit devices and by self-reported questionnaires. Individual changes in the average daily sleep durations between the run-in and each treatment period will be reported using means and 95% CIs. Bland-Altman plots will be constructed to visualize agreement between Fitbit reported and self-reported sleep duration. The effects of treatment on sleep duration will be assessed using GEE with an unstructured variance-covariance matrix for measures on the same day to that night's sleep. This model accounts for possible autocorrelation and linear trends between sleep duration across time. A change between time points is reported (e.g., baseline (2 weeks) and 2 weeks for each intervention period (4 weeks per intervention)) as a value for each intervention period minus value at baseline.
Baseline (2 weeks) and 2 weeks for each intervention period (4 weeks total for each intervention)
Other Outcomes (6)
Mean Within-Subject Difference in Daily Sleep Latency
13-16 weeks
Mean Within-Subject Difference in Daily Sleep Efficiency
13-16 weeks
Mean Within-Subject Difference in Daily Resting Heart Rate
13-16 weeks
- +3 more other outcomes
Study Arms (2)
Personalized Trial ABCCBA
EXPERIMENTALParticipants in Arm 1 will receive a Personalized Trial comprised of three components delivered in a ABCCBA sequence over a total period of 12 weeks, where A-mindfulness, B-yoga, and C-guided walking. Participants in this arm will be prompted to complete 3 x 30-minute intervention sessions weekly during applicable treatment weeks. Interventions will be delivered by a virtual link to online videos recorded by an experienced wellness provider. Participants will be limited to three views of the study-provided intervention content each week.
Personalized Trial CBAABC
EXPERIMENTALParticipants in Arm 2 will receive a Personalized Trial comprised of three components delivered in a CBAABC sequence over a total period of 12 weeks, where A-mindfulness, B-yoga, and C-guided walking. Participants in this arm will be prompted to complete 3 x 30-minute intervention sessions weekly during applicable treatment weeks. Interventions will be delivered by a virtual link to online videos recorded by an experienced wellness provider. Participants will be limited to three views of the study-provided intervention content each week.
Interventions
Participants will receive links for 30-minute videos for all three interventions, for 2 weeks each, 3 times per week, in a specified order (ABCCBA), where A-mindfulness, B-yoga, and C-guided walking.
Participants will receive links for 30-minute videos for all three interventions, for 2 weeks each, 3 times per week, in a specified order (CBAABC), where A-mindfulness, B-yoga, and C-guided walking.
Eligibility Criteria
You may qualify if:
- Women (biological sex at birth)
- Age 40-60 years old
- Northwell employee/affiliate
- Self-reported history of short sleep duration (\<7h per 24-h period) for at least 3 months
- After 2-week run-in, Fitbit-verified short sleep duration and ≥80% adherence of Fitbit wear and survey submission
- Self-report of perceived stress ≥18 using the Perceived Stress Scale (PSS)
- Access to and capable of using a smartphone
- Can regularly wear a Fitbit device
You may not qualify if:
- Men (biological sex at birth)
- Age \< 40 or \>60 years old
- Women who are pregnant
- Not a Northwell employee/affiliate
- No history of short sleep duration or non-adherent to the Fitbit wear and survey submission
- Self-report of perceived stress \<18 using the Perceived Stress Scale (PSS)
- Does not own or cannot regularly access a smartphone
- Cannot regularly wear a Fitbit device
- Unable to complete the study due to cognitive impairment, severe medical or mental illness, or active/prior substance abuse
- Planned surgeries 6 months from study start date
- Participants who have been previously told by a doctor/clinician they have mobility limiting health conditions and/or to not engage in walking 30 minutes, three times per week or yoga
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Institute on Aging (NIA)collaborator
- Northwell Healthlead
Study Sites (1)
Institute of Health System Science
New York, New York, 10022, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Codruta Chiuzan
- Organization
- Northwell Health
Study Officials
- PRINCIPAL INVESTIGATOR
Karina Davidson, PhD, MASc
Northwell Health
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 13, 2023
First Posted
March 29, 2023
Study Start
May 22, 2023
Primary Completion
December 15, 2024
Study Completion
January 3, 2025
Last Updated
February 2, 2026
Results First Posted
February 2, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- The study protocol, including the statistical analysis plan, will be made available in addition to the informed consent form following completion of recruitment but prior to publication of any data from the current study. De-identified, pooled individual participant data will be made available within a year of final participant data collection. We anticipate this data to be available on the Open Science Framework platform indefinitely.
- Access Criteria
- All data and supporting information will be stored on the Open Science Framework, a free web application with no access restrictions.
All collected individual participant data (IPD) will be de-identified and pooled before sharing on the Open Science Framework, along with a data dictionary.